Guocheng Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Guocheng Liu has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
Li Zhang
Department of Obstetrics, Women and Children’s Hospital, Southern University of Science and Technology, Guangzhou, People’s Republic of China
10 shared publications- Hongyan Lin
Bohai University
5 shared publications Jing Peng
Department of Obstetrics, Guangdong Women and Children Hospital, Guangzhou, China
5 shared publicationsJing Jin
Department of Obstetrics, Women and Children’s Hospital, Southern University of Science and Technology, Guangzhou, People’s Republic of China
4 shared publicationsJuwen Zhang
Department of Chemistry, Bohai University, Jinzhou, P. R. China
4 shared publicationsLi Wu
Guangdong Women and Children Hospital, Guangzhou, China
4 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-18
Artemin Serves as a Novel Predictive Biomarker and Exerts a Protective Effect Against Preterm Birth
Background: Preterm birth (PTB) is a major cause of neonatal morbidity and mortality and is closely associated with dysregulated inflammatory responses at the maternal–fetal interface. Excessive activation of inflammatory signaling pathways often represents a terminal event in PTB, highlighting the need to identify upstream immunoregulatory factors involved in disease pathogenesis. This study investigated Artemin (ARTN), a member of the glial cell line-derived neurotrophic factor family, as a potential regulator of inflammation-associated PTB. Methods: A total of 56 pregnant women, including cases of infectious preterm birth (IPB), non-infectious preterm birth (NIPB), and term birth (TB), were enrolled. Maternal plasma samples were analyzed using OLINK proteomics, and placental tissues were examined by immunohistochemistry and Western blotting. Differentially expressed inflammatory proteins were further evaluated using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses. The diagnostic performance of ARTN was assessed using receiver operating characteristic curve analysis. In addition, an LPS-induced mouse model of inflammation-driven PTB was used to evaluate the potential protective effect of exogenous ARTN supplementation. Results: ARTN expression was significantly reduced in maternal circulation and placental tissues in IPB and showed a strong positive correlation with gestational age. Enrichment analyses indicated that ARTN-associated inflammatory proteins were involved in cytokine–cytokine receptor interactions and JAK–STAT signaling. Receiver operating characteristic analysis demonstrated that ARTN exhibited strong discriminatory power for IPB, with an area under the curve of 0.864, and the predictive performance was further enhanced when ARTN was combined with IL-6. In the LPS-induced mouse model, ARTN supplementation markedly reduced preterm delivery and fetal mortality. Conclusion: These findings suggest that ARTN may be involved in inflammation-associated PTB and may have potential value as a candidate predictive biomarker. However, because the human plasma samples were collected across a broad gestational age range and largely in a peripartum clinical context, the present data do not establish ultra-early predictive utility. Given the relatively small sample size and lack of independent validation, these results should be interpreted as preliminary and require confirmation in larger prospective cohorts.
- 1 July 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-18
Open AccessArtemin Serves as a Novel Predictive Biomarker and Exerts a Protective Effect Against Preterm Birth
Background: Preterm birth (PTB) is a major cause of neonatal morbidity and mortality and is closely associated with dysregulated inflammatory responses at the maternal–fetal interface. Excessive activation of inflammatory signaling pathways often represents a terminal event in PTB, highlighting the need to identify upstream immunoregulatory factors involved in disease pathogenesis. This study investigated Artemin (ARTN), a member of the glial cell line-derived neurotrophic factor family, as a potential regulator of inflammation-associated PTB. Methods: A total of 56 pregnant women, including cases of infectious preterm birth (IPB), non-infectious preterm birth (NIPB), and term birth (TB), were enrolled. Maternal plasma samples were analyzed using OLINK proteomics, and placental tissues were examined by immunohistochemistry and Western blotting. Differentially expressed inflammatory proteins were further evaluated using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses. The diagnostic performance of ARTN was assessed using receiver operating characteristic curve analysis. In addition, an LPS-induced mouse model of inflammation-driven PTB was used to evaluate the potential protective effect of exogenous ARTN supplementation. Results: ARTN expression was significantly reduced in maternal circulation and placental tissues in IPB and showed a strong positive correlation with gestational age. Enrichment analyses indicated that ARTN-associated inflammatory proteins were involved in cytokine–cytokine receptor interactions and JAK–STAT signaling. Receiver operating characteristic analysis demonstrated that ARTN exhibited strong discriminatory power for IPB, with an area under the curve of 0.864, and the predictive performance was further enhanced when ARTN was combined with IL-6. In the LPS-induced mouse model, ARTN supplementation markedly reduced preterm delivery and fetal mortality. Conclusion: These findings suggest that ARTN may be involved in inflammation-associated PTB and may have potential value as a candidate predictive biomarker. However, because the human plasma samples were collected across a broad gestational age range and largely in a peripartum clinical context, the present data do not establish ultra-early predictive utility. Given the relatively small sample size and lack of independent validation, these results should be interpreted as preliminary and require confirmation in larger prospective cohorts.
- Open Access
- 26 May 2026
- Published by Springer Nature in npj Biofilms and Microbiomes
Integrative analysis of oral microbiota and its gut transmission with host immunity in term pregnancy
This study aims to evaluate associations between the oral microbiota, metabolites, potential oral-gut transmitted microbes, and systemic immune alterations in term pregnancy. Oral and gut microbiomes, salivary metabolome, peripheral immune cells, and cytokines were profiled in term pregnant (n = 25) and non-pregnant women (n = 25). Species enriched in pregnancy, including Streptococcus anginosus and Prevotella denticola, correlated positively with the NK cell ratio, while Prevotella histicola and Prevotella micans correlated positively with CD56brightCD16- NK cells. Mediation analysis indicated that fatty acids in saliva may not mediate the impact of oral microbiota on peripheral immune changes during pregnancy. Several potential oral-gut transmitted microbes with a higher maternal transfer ratio were positively associated with CD56brightCD16- NK cells and the NK cell ratio, but negatively with Th1 cells and the Th1/Th2 ratio. These findings provide preliminary evidence that pregnancy-related immune shifts may be linked to oral microbiota alterations and microbial transmission.
- 26 May 2026
- Published by Springer Nature in npj Biofilms and Microbiomes
Open AccessIntegrative analysis of oral microbiota and its gut transmission with host immunity in term pregnancy
This study aims to evaluate associations between the oral microbiota, metabolites, potential oral-gut transmitted microbes, and systemic immune alterations in term pregnancy. Oral and gut microbiomes, salivary metabolome, peripheral immune cells, and cytokines were profiled in term pregnant (n = 25) and non-pregnant women (n = 25). Species enriched in pregnancy, including Streptococcus anginosus and Prevotella denticola, correlated positively with the NK cell ratio, while Prevotella histicola and Prevotella micans correlated positively with CD56brightCD16- NK cells. Mediation analysis indicated that fatty acids in saliva may not mediate the impact of oral microbiota on peripheral immune changes during pregnancy. Several potential oral-gut transmitted microbes with a higher maternal transfer ratio were positively associated with CD56brightCD16- NK cells and the NK cell ratio, but negatively with Th1 cells and the Th1/Th2 ratio. These findings provide preliminary evidence that pregnancy-related immune shifts may be linked to oral microbiota alterations and microbial transmission.
- Open Access
- 1 May 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-15
Postpartum Sleep Quality and Early Blood Pressure Levels After Cesarean Delivery in Women with Hypertensive Disorders of Pregnancy: A Prospective Cohort Study
Background: Blood pressure instability is common in the early postoperative period after cesarean delivery among women with hypertensive disorders of pregnancy, while postpartum sleep disturbance is highly prevalent. However, evidence regarding the role of postpartum sleep in early blood pressure regulation remains limited. Objective: To investigate the associations of prenatal and postpartum sleep quality with repeated systolic and diastolic blood pressure levels within 72 h after cesarean delivery in women with hypertensive disorders of pregnancy, and secondarily to explore their associations with categorical postpartum blood pressure control status. Methods: This prospective cohort study enrolled women with hypertensive disorders of pregnancy undergoing cesarean delivery. Prenatal sleep quality was assessed before delivery using the Pittsburgh Sleep Quality Index. Postpartum sleep quality was evaluated repeatedly within 72 h after surgery using the Richards–Campbell Sleep Questionnaire (RCSQ), alongside repeated blood pressure measurements. Multivariable logistic regression and mixed-effects models were applied to examine associations with blood pressure control status and with systolic and diastolic blood pressure, adjusting for relevant clinical and perioperative covariates. Results: A total of 123 women were included. Prenatal sleep quality was not significantly associated with postpartum blood pressure outcomes. In the primary analysis, abnormal postpartum sleep was independently associated with higher systolic (β = 3.63 mmHg, 95% CI 1.82– 5.44) and diastolic blood pressure (β = 1.71 mmHg, 95% CI 0.37– 3.04), while higher overall RCSQ scores and individual sleep item scores were consistently associated with lower systolic and diastolic blood pressure levels. In the secondary analysis, postpartum sleep quality was not significantly associated with binary blood pressure control status. Conclusion: Early postpartum sleep quality was independently associated with continuous blood pressure levels but not with categorical blood pressure control in women with hypertensive disorders of pregnancy after cesarean delivery. These findings support the relevance of sleep assessment in relation to postpartum blood pressure burden, whereas associations with categorical blood pressure control require confirmation in larger studies.
- 1 May 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-15
Open AccessPostpartum Sleep Quality and Early Blood Pressure Levels After Cesarean Delivery in Women with Hypertensive Disorders of Pregnancy: A Prospective Cohort Study
Background: Blood pressure instability is common in the early postoperative period after cesarean delivery among women with hypertensive disorders of pregnancy, while postpartum sleep disturbance is highly prevalent. However, evidence regarding the role of postpartum sleep in early blood pressure regulation remains limited. Objective: To investigate the associations of prenatal and postpartum sleep quality with repeated systolic and diastolic blood pressure levels within 72 h after cesarean delivery in women with hypertensive disorders of pregnancy, and secondarily to explore their associations with categorical postpartum blood pressure control status. Methods: This prospective cohort study enrolled women with hypertensive disorders of pregnancy undergoing cesarean delivery. Prenatal sleep quality was assessed before delivery using the Pittsburgh Sleep Quality Index. Postpartum sleep quality was evaluated repeatedly within 72 h after surgery using the Richards–Campbell Sleep Questionnaire (RCSQ), alongside repeated blood pressure measurements. Multivariable logistic regression and mixed-effects models were applied to examine associations with blood pressure control status and with systolic and diastolic blood pressure, adjusting for relevant clinical and perioperative covariates. Results: A total of 123 women were included. Prenatal sleep quality was not significantly associated with postpartum blood pressure outcomes. In the primary analysis, abnormal postpartum sleep was independently associated with higher systolic (β = 3.63 mmHg, 95% CI 1.82– 5.44) and diastolic blood pressure (β = 1.71 mmHg, 95% CI 0.37– 3.04), while higher overall RCSQ scores and individual sleep item scores were consistently associated with lower systolic and diastolic blood pressure levels. In the secondary analysis, postpartum sleep quality was not significantly associated with binary blood pressure control status. Conclusion: Early postpartum sleep quality was independently associated with continuous blood pressure levels but not with categorical blood pressure control in women with hypertensive disorders of pregnancy after cesarean delivery. These findings support the relevance of sleep assessment in relation to postpartum blood pressure burden, whereas associations with categorical blood pressure control require confirmation in larger studies.
- Open Access
- 14 April 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Temperature-dependent variation in gestational diabetes diagnosis and its impact on macrosomia and LGA infant
Although the influence of temperature on gestational diabetes mellitus (GDM) has been extensively researched, it remains debatable whether this influence s
- 14 April 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessTemperature-dependent variation in gestational diabetes diagnosis and its impact on macrosomia and LGA infant
Although the influence of temperature on gestational diabetes mellitus (GDM) has been extensively researched, it remains debatable whether this influence s
- Open Access
- 10 September 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1624334
Neurodevelopmental trajectories in well-controlled gestational diabetes mellitus offspring: No differences were found at the 6- and 12-month assessments
Objective: To examine the associations between well-controlled gestational diabetes mellitus (GDM) and early neurodevelopmental trajectories in offspring.Methods: This retrospective cohort study included 2810 mother–infant pairs from Guangdong Women and Children Hospital (2016–2022). GDM was diagnosed via a 75 g oral glucose tolerance test at 24–28 gestational weeks, and women with well-controlled GDM were those who maintained blood glucose levels defined as a third-trimester HbA1c < 6% without requiring medication. Neurodevelopment was assessed via the Children’s Neuropsychological and Behavioral Scale-Revision 2016 at 6 and 12 months of age.Results: Among 2810 mother–infant pairs, 451 (16.05%) were diagnosed with GDM. Compared with non-GDM mothers, mothers with GDM had a greater median age (31.00 vs. 29.00 years; P < 0.001) and prepregnancy BMI (21.26 vs. 20.20 kg/m²; P < 0.001). No significant differences were observed in neonatal sex, birth weight or low birth weight ( 0.05). Adjusted multivariate analyses revealed no associations between GDM and neurodevelopmental delay (≥2 subdomains below the threshold) at 6 months (OR = 0.92, 95% CI: 0.57–1.48; P = 0.739) or 12 months (OR = 0.87, 95% CI: 0.58–1.29; P = 0.479).Conclusions: Well-controlled GDM was not associated with adverse neurodevelopmental outcomes in early infancy, suggesting that optimized perinatal management may mitigate risks.
- 10 September 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1624334
Open AccessNeurodevelopmental trajectories in well-controlled gestational diabetes mellitus offspring: No differences were found at the 6- and 12-month assessments
Objective: To examine the associations between well-controlled gestational diabetes mellitus (GDM) and early neurodevelopmental trajectories in offspring.Methods: This retrospective cohort study included 2810 mother–infant pairs from Guangdong Women and Children Hospital (2016–2022). GDM was diagnosed via a 75 g oral glucose tolerance test at 24–28 gestational weeks, and women with well-controlled GDM were those who maintained blood glucose levels defined as a third-trimester HbA1c < 6% without requiring medication. Neurodevelopment was assessed via the Children’s Neuropsychological and Behavioral Scale-Revision 2016 at 6 and 12 months of age.Results: Among 2810 mother–infant pairs, 451 (16.05%) were diagnosed with GDM. Compared with non-GDM mothers, mothers with GDM had a greater median age (31.00 vs. 29.00 years; P < 0.001) and prepregnancy BMI (21.26 vs. 20.20 kg/m²; P < 0.001). No significant differences were observed in neonatal sex, birth weight or low birth weight ( 0.05). Adjusted multivariate analyses revealed no associations between GDM and neurodevelopmental delay (≥2 subdomains below the threshold) at 6 months (OR = 0.92, 95% CI: 0.57–1.48; P = 0.739) or 12 months (OR = 0.87, 95% CI: 0.58–1.29; P = 0.479).Conclusions: Well-controlled GDM was not associated with adverse neurodevelopmental outcomes in early infancy, suggesting that optimized perinatal management may mitigate risks.
- 2 July 2025
- Published by Springer Nature in Endocrine
- Vol. 90 (1) , 31-38
Association between different response patterns during oral glucose tolerance test and postpartum glucose intolerance in women with gestational diabetes
Purpose Our study aimed to assess the associations of the response patterns during gestational oral glucose tolerance test (OGTT) with postpartum glucose intolerance (PGI) in women with gestational diabetes mellitus (GDM). Methods This cohort study included 5348 GDM women who underwent the OGTT both 24–28 weeks during pregnancy and 4–12 weeks postpartum from January 2017 to June 2022. Gestational OGTT response patterns included individual time-point glucose values, glucose response trajectories, and GDM subtypes. PGI was defined as women with postpartum pre-diabetes or diabetes. Cox proportional hazards regression models were used to assess the risks of PGI according to different response patterns. Results During a median follow-up of 6.3 weeks post-delivery, 1727 (32.3%) women had PGI. Each time-point OGTT glucose were positively associated with PGI. Four OGTT glucose trajectories were fitted: 515 (9.6%) moderate increase following decrease, 557 (10.4%) sustained low-level increase, 3918 (73.3%) moderate increase following slow decrease, and 358 (6.7%) rapid increase following slow decrease. Compared with women with glucose moderate increase following decrease, those with rapid increase following slow decrease had the highest risk of PGI, followed by those with moderate increase following slow decrease. For GDM subtypes, 442 (8.3%) were isolated fasting hyperglycemia (IFH), 4227 (79.0%) were isolated post-load hyperglycemia (IPH), and 679 (12.7%) were combined hyperglycemia (CH). Compared with women with IFH, CH indicated the highest risk of PGI, followed by IPH. Conclusions Our findings indicate that distinct OGTT response patterns are associated with varying risks of PGI in women with GDM.
- 2 July 2025
- Published by Springer Nature in Endocrine
- Vol. 90 (1) , 31-38
Association between different response patterns during oral glucose tolerance test and postpartum glucose intolerance in women with gestational diabetes
Purpose Our study aimed to assess the associations of the response patterns during gestational oral glucose tolerance test (OGTT) with postpartum glucose intolerance (PGI) in women with gestational diabetes mellitus (GDM). Methods This cohort study included 5348 GDM women who underwent the OGTT both 24–28 weeks during pregnancy and 4–12 weeks postpartum from January 2017 to June 2022. Gestational OGTT response patterns included individual time-point glucose values, glucose response trajectories, and GDM subtypes. PGI was defined as women with postpartum pre-diabetes or diabetes. Cox proportional hazards regression models were used to assess the risks of PGI according to different response patterns. Results During a median follow-up of 6.3 weeks post-delivery, 1727 (32.3%) women had PGI. Each time-point OGTT glucose were positively associated with PGI. Four OGTT glucose trajectories were fitted: 515 (9.6%) moderate increase following decrease, 557 (10.4%) sustained low-level increase, 3918 (73.3%) moderate increase following slow decrease, and 358 (6.7%) rapid increase following slow decrease. Compared with women with glucose moderate increase following decrease, those with rapid increase following slow decrease had the highest risk of PGI, followed by those with moderate increase following slow decrease. For GDM subtypes, 442 (8.3%) were isolated fasting hyperglycemia (IFH), 4227 (79.0%) were isolated post-load hyperglycemia (IPH), and 679 (12.7%) were combined hyperglycemia (CH). Compared with women with IFH, CH indicated the highest risk of PGI, followed by IPH. Conclusions Our findings indicate that distinct OGTT response patterns are associated with varying risks of PGI in women with GDM.
- Open Access
- 19 June 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1554840
Association between blood essential metal elements in early pregnancy and gestational diabetes mellitus
Objectives: The purpose was to assess the levels of iron (Fe), magnesium (Mg), copper (Cu), calcium (Ca), zinc (Zn) in the blood of pregnant women during early pregnancy, and to evaluate their potential association with gestational diabetes mellitus (GDM).Methods: We enrolled 9,112 pregnant women who underwent testing for essential metal elements at Guangdong Women and Children Hospital during the first trimester in 2015–2022. The basic information of pregnant women and peripheral blood samples were collected, and five essential metal elements in whole blood were detected by atomic absorption spectrometry. The relationship between these essential metal elements and GDM was analyzed using the generalized linear regression model (GLM), weighted quantile sum regression (WQS), quantile g-computation regression (QGC), and Bayesian kernel machine regression (BKMR).Results: Analysis of the correlation between essential metal elements and GDM revealed significant associations. Compared with the first quantile concentration level, the fourth quantile level of Fe (OR = 1.347, 95%CI: 1.158 ~ 1.568), Zn (OR = 1.379, 95%CI: 1.185 ~ 1.606) and Mg (OR = 1.192, 95%CI: 1.022 ~ 1.392) exhibited significant associations with GDM. Restricted cubic spline (RCS) analysis showed a positive linear relationship between Fe, Zn, and Mg and GDM risk (Poverall < 0.05 and Pnon-linear > 0.05). WQS analysis showed that the WQS index had a significant positive correlation with GDM (OR = 1.129, 95%CI: 1.023 ~ 1.247), with Fe (0.446) having greater weight. QGC analysis revealed a positive correlation between the combined action of five essential metal elements and GDM risk (OR = 1.161, 95%CI: 1.075 ~ 1.248), with Zn (0.454) and Fe (0.417) showing greater influence. In BKMR analysis, the combined effect of all essential metal elements on GDM showed an overall upward trend, with Fe (PIP = 0.772) having the most significant influence. No interaction between essential metal elements and GDM was found in this study.Conclusion: Higher levels of Fe, Zn and Mg were positively correlated with GDM risk. The combined action of five essential metal elements was positively correlated with GDM, with Fe identified as playing the most significant role.
- 19 June 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1554840
Open AccessAssociation between blood essential metal elements in early pregnancy and gestational diabetes mellitus
Objectives: The purpose was to assess the levels of iron (Fe), magnesium (Mg), copper (Cu), calcium (Ca), zinc (Zn) in the blood of pregnant women during early pregnancy, and to evaluate their potential association with gestational diabetes mellitus (GDM).Methods: We enrolled 9,112 pregnant women who underwent testing for essential metal elements at Guangdong Women and Children Hospital during the first trimester in 2015–2022. The basic information of pregnant women and peripheral blood samples were collected, and five essential metal elements in whole blood were detected by atomic absorption spectrometry. The relationship between these essential metal elements and GDM was analyzed using the generalized linear regression model (GLM), weighted quantile sum regression (WQS), quantile g-computation regression (QGC), and Bayesian kernel machine regression (BKMR).Results: Analysis of the correlation between essential metal elements and GDM revealed significant associations. Compared with the first quantile concentration level, the fourth quantile level of Fe (OR = 1.347, 95%CI: 1.158 ~ 1.568), Zn (OR = 1.379, 95%CI: 1.185 ~ 1.606) and Mg (OR = 1.192, 95%CI: 1.022 ~ 1.392) exhibited significant associations with GDM. Restricted cubic spline (RCS) analysis showed a positive linear relationship between Fe, Zn, and Mg and GDM risk (Poverall < 0.05 and Pnon-linear > 0.05). WQS analysis showed that the WQS index had a significant positive correlation with GDM (OR = 1.129, 95%CI: 1.023 ~ 1.247), with Fe (0.446) having greater weight. QGC analysis revealed a positive correlation between the combined action of five essential metal elements and GDM risk (OR = 1.161, 95%CI: 1.075 ~ 1.248), with Zn (0.454) and Fe (0.417) showing greater influence. In BKMR analysis, the combined effect of all essential metal elements on GDM showed an overall upward trend, with Fe (PIP = 0.772) having the most significant influence. No interaction between essential metal elements and GDM was found in this study.Conclusion: Higher levels of Fe, Zn and Mg were positively correlated with GDM risk. The combined action of five essential metal elements was positively correlated with GDM, with Fe identified as playing the most significant role.
- Open Access
- 10 February 2025
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 24 (1) , 1-8
Impact of maternal lipid profiles on offspring birth size in late pregnancy among women with and without gestational diabetes
Maternal glucose and lipid levels are known to influence fetal growth. However, data on how maternal lipid profiles affect birth size in women with gestational diabetes (GDM) compared with those without GDM are scarce. This retrospective study included 10,490 women with singleton pregnancies (2351 with GDM and 8139 without GDM) between December 2016 and July 2022. Maternal serum levels of total cholesterol (TC), triglycerides (TGs), low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol were measured at 28–42 weeks of gestation. Maternal glucose levels were determined using the 2-h oral glucose tolerance test. The neonatal birth weight was obtained at delivery and standardized as the birth weight z score according to the INTERGROWTH-21st standards. Compared with women without GDM, those with GDM presented increased mean TG levels and decreased levels of TC, HDL cholesterol, and LDL cholesterol. TG levels were positively associated with birth weight in both the GDM and non-GDM groups, whereas TC, HDL cholesterol, and LDL cholesterol levels were mildly negatively correlated with birth weight. In the GDM group, an increase of 1 mmol/L in maternal TGs correlated with a 28.4 g increase in birth weight (95% CI: 17.8 to 39.1), whereas increases of 1 mmol/L in TC (-19.2 g; 95% CI: -31.9 to -6.5), HDL cholesterol (-120.7 g; 95% CI: -164.8 to -76.6), and LDL cholesterol (-22.2 g; 95% CI: -40.4 to -4) were associated with a decrease in birth weight. Compared with women with GDM with TG levels ≤ the 10th percentile, those with TG levels ≥ the 90th percentile had increased risks of large-for-gestational-age offspring (adjusted OR: 3.09; 95% CI: 1.51–6.30) and macrosomia (adjusted OR: 4.04; 95% CI: 1.37–11.93); this risk was stronger than that in women without GDM. This study provides evidence of a significant association between maternal lipid levels during late pregnancy and offspring birth size. However, the observational nature of the study limits the ability to establish causal relationships regarding the direct impact of lipid levels on birth size. Additionally, the influence of maternal lipid profiles is disproportionately greater in women with GDM than in women without GDM.
- 10 February 2025
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 24 (1) , 1-8
Open AccessImpact of maternal lipid profiles on offspring birth size in late pregnancy among women with and without gestational diabetes
Maternal glucose and lipid levels are known to influence fetal growth. However, data on how maternal lipid profiles affect birth size in women with gestational diabetes (GDM) compared with those without GDM are scarce. This retrospective study included 10,490 women with singleton pregnancies (2351 with GDM and 8139 without GDM) between December 2016 and July 2022. Maternal serum levels of total cholesterol (TC), triglycerides (TGs), low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol were measured at 28–42 weeks of gestation. Maternal glucose levels were determined using the 2-h oral glucose tolerance test. The neonatal birth weight was obtained at delivery and standardized as the birth weight z score according to the INTERGROWTH-21st standards. Compared with women without GDM, those with GDM presented increased mean TG levels and decreased levels of TC, HDL cholesterol, and LDL cholesterol. TG levels were positively associated with birth weight in both the GDM and non-GDM groups, whereas TC, HDL cholesterol, and LDL cholesterol levels were mildly negatively correlated with birth weight. In the GDM group, an increase of 1 mmol/L in maternal TGs correlated with a 28.4 g increase in birth weight (95% CI: 17.8 to 39.1), whereas increases of 1 mmol/L in TC (-19.2 g; 95% CI: -31.9 to -6.5), HDL cholesterol (-120.7 g; 95% CI: -164.8 to -76.6), and LDL cholesterol (-22.2 g; 95% CI: -40.4 to -4) were associated with a decrease in birth weight. Compared with women with GDM with TG levels ≤ the 10th percentile, those with TG levels ≥ the 90th percentile had increased risks of large-for-gestational-age offspring (adjusted OR: 3.09; 95% CI: 1.51–6.30) and macrosomia (adjusted OR: 4.04; 95% CI: 1.37–11.93); this risk was stronger than that in women without GDM. This study provides evidence of a significant association between maternal lipid levels during late pregnancy and offspring birth size. However, the observational nature of the study limits the ability to establish causal relationships regarding the direct impact of lipid levels on birth size. Additionally, the influence of maternal lipid profiles is disproportionately greater in women with GDM than in women without GDM.
- 11 May 2024
- Published by Springer Nature in Acta Diabetologica
- Vol. 61 (10) , 1225-1230
Association between hemoglobin A1c trajectory during pregnancy and adverse birth outcomes among non-gestational diabetic women
Aims Previous studies have shown that higher hemoglobin A1c (HbA1c) levels within the normal range during pregnancy can increase the risk of adverse birth outcomes. However, the effects of the longitudinal HbA1c trajectory during pregnancy on adverse birth outcomes among non-gestational diabetic women are poorly characterized. We aimed to identify HbA1c trajectory during pregnancy among non-gestational diabetic women and to estimate their associations with adverse birth outcomes. Methods Data was extracted from the Information System of Guangdong Women and Children Hospital, China, from January 2017 to July 2022. This study involved 13,979 women who did not have gestational diabetes mellitus and underwent repeated HbA1c measurements during pregnancy. Latent mixture modeling was used to identify HbA1c trajectory groups. Logistic regression was applied to explore the associations between HbA1c trajectory groups and adverse birth outcomes, including preterm delivery, low birth weight, macrosomia, small for gestational age, and large for gestational age (LGA). Results Three HbA1c trajectory groups were identified: low-stable (range 4.0% [20 mmol/mol]–4.4% [25 mmol/mol]), moderate-stable (range 4.6% [27 mmol/mol]–5.1% [32 mmol/mol]), and elevated-increasing (range 5.0% [31 mmol/mol]–5.6% [38 mmol/mol]). Compared with the low-stable HbA1c group, the elevated-increasing group had a higher risk of preterm delivery and LGA. The adjusted OR (95% CIs) were 1.67 (1.13, 2.49) and 1.47 (1.01, 2.12) for preterm delivery and LGA, respectively. Conclusions Among non-gestational diabetic women, the elevated-increasing HbA1c trajectory group was associated with a higher risk of preterm delivery and LGA. This finding emphasizes the importance of maintaining optimal HbA1c levels throughout pregnancy.
- 11 May 2024
- Published by Springer Nature in Acta Diabetologica
- Vol. 61 (10) , 1225-1230
Association between hemoglobin A1c trajectory during pregnancy and adverse birth outcomes among non-gestational diabetic women
Aims Previous studies have shown that higher hemoglobin A1c (HbA1c) levels within the normal range during pregnancy can increase the risk of adverse birth outcomes. However, the effects of the longitudinal HbA1c trajectory during pregnancy on adverse birth outcomes among non-gestational diabetic women are poorly characterized. We aimed to identify HbA1c trajectory during pregnancy among non-gestational diabetic women and to estimate their associations with adverse birth outcomes. Methods Data was extracted from the Information System of Guangdong Women and Children Hospital, China, from January 2017 to July 2022. This study involved 13,979 women who did not have gestational diabetes mellitus and underwent repeated HbA1c measurements during pregnancy. Latent mixture modeling was used to identify HbA1c trajectory groups. Logistic regression was applied to explore the associations between HbA1c trajectory groups and adverse birth outcomes, including preterm delivery, low birth weight, macrosomia, small for gestational age, and large for gestational age (LGA). Results Three HbA1c trajectory groups were identified: low-stable (range 4.0% [20 mmol/mol]–4.4% [25 mmol/mol]), moderate-stable (range 4.6% [27 mmol/mol]–5.1% [32 mmol/mol]), and elevated-increasing (range 5.0% [31 mmol/mol]–5.6% [38 mmol/mol]). Compared with the low-stable HbA1c group, the elevated-increasing group had a higher risk of preterm delivery and LGA. The adjusted OR (95% CIs) were 1.67 (1.13, 2.49) and 1.47 (1.01, 2.12) for preterm delivery and LGA, respectively. Conclusions Among non-gestational diabetic women, the elevated-increasing HbA1c trajectory group was associated with a higher risk of preterm delivery and LGA. This finding emphasizes the importance of maintaining optimal HbA1c levels throughout pregnancy.